Prelude Capital Management’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Prelude Capital Management’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-44,115	Closed	-$493K	–	1686
2022 Q4	$493K	Buy	+44,115	New	+$428K	0.03%	579
2020 Q4	–	Sell	-200	Closed	-$4K	–	2189
2020 Q3	$4K	Buy	+200	New	+$4.68K	﹤0.01%	1605

Other funds holding OYST

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Prelude Capital Management's OYST Position: Q1 2023 in Review

Prelude Capital Management sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 44,115 shares — an estimated $493K sold.

Prelude Capital Management first reported a position in OYST in Q3 2020 and held it in 2 quarters. The position peaked at $493K in Q4 2022. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

Prelude Capital Management reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Prelude Capital Management sold 44,115 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $493K.
Prelude Capital Management first reported a position in Oyster Point Pharma, Inc. Common Stock in Q3 2020 and held it in 2 quarters.
Prelude Capital Management's Oyster Point Pharma, Inc. Common Stock position peaked at $493K in Q4 2022.
1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on Prelude Capital Management's 13F filing for Q1 2023, filed 15 May 2023.